John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 5,915 shares at $4.58 ($27K) on 2025-02-12, disclosed to the SEC on 2025-02-14.
Open-market sale of $27k SERA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |